The oral combination of xanomeline and trospium effectively treats schizophrenia without unwanted side effects.
dementia
Posted inNeuroscience, New Drugs, Regulatory
Oligomannate: Finally New Drug to Treat Alzheimer’s Disease
Innovative Chinese medicine eliminates gut microbiota dysbiosis, and it helps slow the progression of dementia in Alzheimer’s disease.
Posted inNeuroscience, New Drugs, Regulatory
Igalmi: New Drug for Agitation in Schizophrenia and Bipolar Disorder
BioXcel Therapeutics has offered a fast-action mouth-dissolving sublingual film formulation of dexmedetomidine.
Posted inClinical Trials, In the Pipeline, Neuroscience
Treating Parkinson’s Disease: Betting on Alpha-Synuclein
The pharmaceutical industry continues to fight hard against the devastating neurodegenerative disease.
Posted inClinical Trials, Neuroscience
Buntanetap: Breakthrough in Treatment of Alzheimer’s and Parkinson’s
Buntanetap acts simultaneously on three neurotoxic proteins responsible for neurodegenerative disorders: amyloid beta, alpha-synuclein, and tau protein.
Posted inAutoimmune Diseases, Neuroscience, Oncology, Pharma & Biotech
Bit Bio: Mass and Problem-Free Production of Any Human Cells
Human cells are needed for scientific research, development of new drugs, and creation of cell therapies.
Posted inMetabolism, New Drugs, Regulatory
Wegovy: Most Effective Drug for Weight Loss
Semaglutide can help you lose 15% of your excess weight in a year. And even more.